SCHEMBL12696744

SCHEMBL12696744

C=C(N)/N=C(\N(C)N)N1CCN(c2ccc(OC)cn2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.44
▸ DHFR P00374 1/20 0.43
▸ ME2 P23368 1/20 0.41
▸ ME1 P48163 1/20 0.41
▸ ME3 Q16798 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.40
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ PPARA Q07869 1/20 0.37
▸ HSD17B10 Q99714 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ PANK3 Q9H999 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12696731 0.82 TAAR1 (0.55) TAAR1KMT2AMEN1LMNAL3MBTL1
SCHEMBL12696741 0.72 GAA (0.39) HRH3TAAR1KDM4EALDH1A1HTT
SCHEMBL12696765 0.72 GPR119 (0.47) HRH3DHFRME2ME1ME3
SCHEMBL12696767 0.70 TAAR1 (0.39) TAAR1KMT2AMEN1LMNAL3MBTL1
SCHEMBL3920532 0.69 DHFR (0.48) HRH3DHFRME2ME1ME3
SCHEMBL14650779 0.69 UBE2T (0.51) HRH3DHFRME2ME1ME3
SCHEMBL9366521 0.69 HRH3 (0.65) HRH3DHFRME2ME1ME3
SCHEMBL8931702 0.68 KMT2A (0.51) HRH3DHFRME2ME1ME3
SCHEMBL27837554 0.68 UBE2T (0.50) HRH3DHFRKMT2AMEN1HSD17B10
SCHEMBL16473496 0.67 GPR119 (0.64) HRH3ME2ME1ME3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012126984-A1 NOVEL SUBSTITUTED TRIAZOLYL PIPERAZINE AND TRIAZOLYL PIPERIDINE DERIVATIVES AS GAMMA SECRETASE MODULATORS Janssen Pharmaceuticals, Inc. (US) 2012-09-27 — — WO disclosed
Send feedback